scholarly journals Combined Hormonal Contraception and Women’s sexual function: a cross-sectional pilot study in a Cohort of Danish women

Author(s):  
Nanna Læssøe ◽  
◽  
Sarah Wåhlin ◽  
Ellids Kristensen ◽  
Anette Pedersen ◽  
...  
2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Felix Mwembi Oindi ◽  
Alfred Murage ◽  
Valentino Manase Lema ◽  
Abraham Mwaniki Mukaindo

Abstract Background Sexual function plays an essential role in the bio-psychosocial wellbeing and quality of life of women and disturbances in sexual functioning often result in significant distress. Female sexual dysfunction (FSD) and subfertility are common problems affecting approximately 43 and 20% of women respectively. However, despite the high prevalence of both conditions, little has been studied on the effects of subfertility on sexual functioning especially in sub-Saharan Africa. We set out to compare the prevalence of female sexual dysfunction in patients on assessment for sub-fertility and those either seeking or already on fertility control services at a private tertiary teaching hospital in Kenya. Methods This was an analytical cross sectional study. Eligible women of reproductive age (18–49 years), attending the gynaecological clinics with complaints of subfertility and those seeking fertility control services were requested to fill a general demographic tool containing personal data and the Female Sexual Function Index (FSFI) questionnaire after informed consent. Prevalence of sexual dysfunction was calculated as a percentage of patients not achieving an overall FSFI score of 26.55. Univariate and multivariate analysis were done to compare clinical variables to delineate the potential association. Results The prevalence of female sexual dysfunction was 31.2% in the subfertile group and 22.6% in fertility control group. The difference was not statistically significant (p = 0.187). The mean domain and overall female sexual function scores were lower in the subfertile group than the fertility control group though this was not statistically significant. The most prevalent sexual domain dysfunctions in both the subfertility and fertility control groups were desire and arousal while the least in both groups was satisfaction dysfunction. Subfertility type was not associated with sexual dysfunction. Higher education attainment was protective of female sexual dysfunction in the subfertile group while use of hormonal contraception was associated with greater sexual impairment in the fertility control group. On logistic regression analysis, higher maternal age and alcohol use appeared to be protective against sexual dysfunction. Conclusion The present study demonstrated no association between the fertility status and the prevalence female sexual dysfunction. Subfertility type was not associated with sexual dysfunction. Education level and hormonal contraception use were associated with female sexual dysfunction in the subfertile and fertility control groups respectively while alcohol use and higher maternal age appeared to be protective against sexual dysfunction.


2021 ◽  
Vol 8 (2) ◽  
pp. 100-107
Author(s):  
Farida Yuliani ◽  
Fitria Edni Wari ◽  
Ferilia Adiesti ◽  
Nurun Ayati Khasanah

Hormonal changes due to the use of hormonal contraceptives are known to be one of the causes of sexual dysfunction. Impaired sexual function can affect the ability to establish and maintain intimate relationships with a partner, and interfere with mental health such as anxiety and depression. This descriptive study using a cross-sectional design aims to describe the sexual function of acceptors of hormonal contraception Depo Medroxyprogesterone Acetate (DMPA). The population of this study was women who used DMPA hormonal contraception. Sample selection is done by total sampling. The data was collected using the Female Sexual Function Index (FSFI) questionnaire, then the data were tabulated and analyzed descriptively. The results showed that most of the DMPA contraceptive acceptors experienced sexual dysfunction and most of the acceptors had used DMPA hormonal contraception for 2 years. DMPA's systemic hypo-estrogenic effect causes vaginal mucosal atrophy, vaginal dryness, and dyspareunia, causing sexual dysfunction. Midwives as health care providers need to have open discussions with hormonal contraceptive acceptors regarding their sexual function so that contraceptive acceptors continue to use effective contraception to prevent pregnancy and continue to provide emotional and sexual support in a woman's life.   Keywords: Sexual Function, Acceptor, DMPA   ABSTRAK   Perubahan hormonal akibat penggunaan kontrasepsi hormonal diketahui menjadi salah satu penyebab disfungsi sexual. Gangguan fungsi seksual dapat mempengaruhi kemampuan untuk membangun dan mempertahankan hubungan intim dengan pasangan, dan mengganggu kesehatan mental seperti kecemasan dan depresi. Penelitian deskriptif ini  menggunakan desain Cross Sectional bertujuan untuk mengetahui gambaran fungsi seksual akseptor kontrasepsi hormonal Depo Medroxyprogesterone Acetate (DMPA). Populasi penelitian ini adalah wanita yang menggunakan kontrasepsi hormonal DMPA. Pemilihan sampel dilakukan secara total sampling. Pengumpulan data menggunakan kuesioner Female Sexual Function Index (FSFI) selanjutnya data ditabulasi dan dianalisis secara deskriptif. Hasil penelitian menunjukkan bahwa sebagian besar akseptor kontrasepsi DMPA mengalami disfungsi seksual dan sebagian besar akseptor sudah ≥ 2 tahun  menggunakan kontrasepsi hormonal DMPA. Efek hipo estrogenik sistemik DMPA ini menyebabkan mukosa vagina atrofi, kekeringan vagina dan dispareunia sehingga menyebabkan gangguan fungsi seksual. Bidan sebagai pemberi pelayanan kesehatan perlu melakukan diskusi secara terbuka dengan akseptor kontrasepsi hormonal terkait fungsi seksual mereka sehingga akseptor kontrasepsi tetap menggunakan kontrasepsi efektif untuk mencegah kehamilan dan tetap memberi dukungan secara emosional dan seksual di kehidupan seorang wanita.   Kata kunci : Fungsi Seksual, Akseptor, DMPA


2019 ◽  
Vol 1 (1) ◽  
pp. 19-26
Author(s):  
I. V. Kuznetsova

The review of the literature presents data on the possible risks of using combined hormonal contraception and the possibilities of prescribing purely progestogenic contraception as an alternative to the use of combined means. Progestogen contraceptives include a group of agents with different routes of administration, doses and characteristics of progestins, which have a number of differences in the ratio of benefits and risks, availability, reversibility and other properties of contraception. Particular attention is paid to purely progestogenic tablets containing desogestrel, as a means equivalent in effectiveness to combination contraceptives, but safer. Safety issues are considered in the context of the use of breastfeeding women, as well as from the standpoint of the risk of arterial and venous thrombosis. The issues of non-contraceptive positive effects of purely progestogenic contraceptives are covered.


Author(s):  
M. Tasdik Hasan ◽  
Sahadat Hossain ◽  
Rajat Das Gupta ◽  
Vivek Podder ◽  
Naima Afroz Mowri ◽  
...  

Author(s):  
Shung-Tai Ho ◽  
Tso-Chou Lin ◽  
Chun-Chang Yeh ◽  
Kuang-I Cheng ◽  
Wei-Zen Sun ◽  
...  

Background: Long-term use of opioids for chronic noncancer pain is associated with sex hormone disturbances. The interferences with sex hormones, sexual function, and depression were investigated in patients with chronic noncancer pain. Methods: A cross-sectional multicenter survey was conducted on 170 officially registered outpatients receiving long-term opioid treatment in nine medical centers in Taiwan between October 2018 and July 2019. Serum sex hormone levels were examined after the collection of self-administered questionnaires containing the Taiwanese version of the Brief Pain Inventory, depressive status, and sexual function interference. Results: Among 117 (68.8%) questionnaire responses from 170 enrolled outpatients, 38 women and 62 men completed the sex hormone tests, among whom only 23 (23%) had previously received blood hormone tests. Low serum total testosterone levels were detected in 34 (89.5%) women (<30 ng/dL) and 31 (50%) men (<300 ng/dL). Over 60% of women and men reported reduced sexual desire and function despite a nearly 50% reduction in pain intensity and daily function interference over the previous week after opioid treatment. Women generally had higher risks of a depression diagnosis (p = 0.034) and severe depressive symptoms (p = 0.003) and nonsignificantly lower opioid treatment duration (median 81 vs. 120 months) and morphine milligram equivalent (median 134 vs. 165 mg/day) compared with men. Conclusions: This survey demonstrated the high prevalence of depression diagnosis, low sex hormone levels, and reduced sexual function among Taiwanese patients with chronic noncancer pain receiving prolonged opioid therapy. Regular hypogonadal screenings are recommended for further management.


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 929.2-929
Author(s):  
G. V. Espasa ◽  
L. Gonzalez Lucero ◽  
Y. Soria Curi ◽  
A. L. Barbaglia ◽  
S. M. Mazza ◽  
...  

Background:Sexual dysfunction is the alteration in one or several phases of sexual activity (desire, excitement, plateau, orgasm and resolution), which can culminate in frustration, pain and a decrease in the frequency of sexual intercourse. There are few studies that associate sexual dysfunction with Systemic Lupus Erythematosus (SLE) due to the difficulty in assessing it and its multifactorial cause.Objectives:Determine the frequency of sexual dysfunction and analyze associated factors in patients with SLE.Methods:A descriptive cross-sectional study was conducted. We included patients who attended the Rheumatology unit between May and July 2019; over 18 years of age, with a diagnosis of SLE according to the ACR 1997 and / or SLICC 2012 criteria, and healthy patients matched by age as control. Demographic and disease-related variables were studied. The DASS-21 (Depression Anxiety Stress Scale) scale that evaluates depression, anxiety and stress, and the Female Sexual Function Index (FSFI) that assesses 6 domains (desire, excitement, lubrication, orgasms, satisfaction and pain) were applied with a cut-off point ≤ 26.5 to define sexual dysfunction. Women over 50 years old, with secondary Sjogren’s syndrome, menopause, severe depression and illiterate patients were excluded.Results:One hundred and twenty three women were included (60 with SLE and 63 controls), with a mean age of 34.3 ± 8.3 and 31.7 ± 4.4 years respectively. The prevalence of sexual dysfunction in the SLE group was 71.7%; 95% CI = [58.5 – 82.5], and 23.8%, 95% CI = [13.9 – 36.2] in healthy patients. There were significant differences in all domains of sexual function between women with SLE and healthy group. In the desire, excitement and pain domains the differences were notable. The total FSFI score in patients with SLE was 18.2 ± 11.2 and in healthy women 28.3 ± 6.9 (p=0.001). Stress, anxiety and depression were observed in 58.4%, 58.3% and 50% of women with SLE and 19%, 20.6% and 28.5% of healthy women respectively (p=0.001). No association was found between sexual dysfunction and age, age at diagnosis, disease activity or treatment (pNS). No association was found in patients with SLE when analyzing the effect of sexual dysfunction in stress, depression and anxiety variables, in opposition to the healthy group (p<0.05).Conclusion:The prevalence of sexual dysfunction in patients with SLE was high (71.7%). Depression, Anxiety, and Stress were not decisive variables in Sexual Dysfunction.Disclosure of Interests:None declared


Author(s):  
Siddrah Irfan ◽  
Nor Sheereen Zulkefly

AbstractObjectivesThe present pilot study examined the associations between attachment relationships, psychological problems, and negative automatic thoughts among late adolescents in Rawalpindi, Pakistan.SubjectsA total of 98 participants (male = 49, female = 49) were recruited from government colleges in Rawalpindi, Pakistan.MethodsThe measures used to assess the research variables of this cross sectional study were the Inventory of Parent-Peer Attachment (IPPA-Urdu), Depression, Anxiety, and Stress Scale (DASS-Urdu), and the Automatic Thought Questionnaire (ATQ-Urdu).ResultsAll of these measures had good reliabilities. Findings of the correlation analyses demonstrated that maternal, paternal and peer attachment relationships were negatively related to symptoms of depression and anxiety as well as to negative automatic thoughts. On the other hand, depressive and anxiety symptoms were positively associated with negative automatic thoughts. Additionally, findings suggested that future studies must investigate adolescents from two-parent households and exclude those with only one living parent.ConclusionThe results underscored the need for further investigations of the linkages between attachment relationships, negative automatic thoughts and psychological problems on larger samples.


Sign in / Sign up

Export Citation Format

Share Document